Page last updated: 2024-11-02

moxonidine and Coronary Artery Disease

moxonidine has been researched along with Coronary Artery Disease in 2 studies

moxonidine: structure given in first source

Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sarac, B1
Korkmaz, O1
Altun, A1
Bagcivan, I1
Göksel, S1
Yildirim, S1
Berkan, O1
Bolliger, D1
Seeberger, MD1
Lurati Buse, GA1
Christen, P1
Gürke, L1
Filipovic, M1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Effects of Small Doses of Moxonidine in Patients Undergoing Vascular Surgery[NCT00244504]Phase 3141 participants (Actual)Interventional2002-11-30Terminated (stopped due to Study was stopped after pre-definied interim analysis because of no effects)
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trials

1 trial available for moxonidine and Coronary Artery Disease

ArticleYear
Randomized clinical trial of moxonidine in patients undergoing major vascular surgery.
    The British journal of surgery, 2007, Volume: 94, Issue:12

    Topics: Aged; Coronary Artery Disease; Double-Blind Method; Female; Hemodynamics; Hospitalization; Humans; I

2007

Other Studies

1 other study available for moxonidine and Coronary Artery Disease

ArticleYear
Investigation of the vasorelaxant effects of moxonidine and its relaxation mechanism on the human radial artery when used as a coronary bypass graft.
    Interactive cardiovascular and thoracic surgery, 2015, Volume: 21, Issue:3

    Topics: Antihypertensive Agents; Coronary Artery Bypass; Coronary Artery Disease; Female; Humans; Imidazoles

2015